Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Cox

Showing results (31-40 of 164) with videos related to

Pageof 17
Sort By:
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|February 19, 2011
A clinical risk score for the prediction of very late stent thrombosis in drug eluting stent patientsKenneth W Baran, John M Lasala, David A Cox, et al.
The American Journal of Cardiology|December 3, 2014
Effect of anemia on frequency of short- and long-term clinical events in acute coronary syndromes (from the Acute Catheterization and Urgent Intervention Triage Strategy Trial)Vijay Kunadian, Roxana Mehran, A Michael Lincoff, et al.
Circulation. Cardiovascular Interventions|February 2, 2010
Impact of femoral vascular closure devices and antithrombotic therapy on access site bleeding in acute coronary syndromes: The Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) trialTimothy A Sanborn, Ramin Ebrahimi, Steven V Manoukian, et al.
Diabetes, Obesity & Metabolism|June 23, 2021
Efficacy and safety of dulaglutide 3.0 and 4.5 mg in patients aged younger than 65 and 65 years or older: Post hoc analysis of the AWARD-11 trialJuan P Frias, Enzo Bonora, Luis Nevárez Ruiz, et al.
Diabetes Care|January 5, 2021
Efficacy and Safety of Dulaglutide 3.0 mg and 4.5 mg Versus Dulaglutide 1.5 mg in Metformin-Treated Patients With Type 2 Diabetes in a Randomized Controlled Trial (AWARD-11)Juan P Frias, Enzo Bonora, Luis Nevarez Ruiz, et al.
Diabetes, Obesity & Metabolism|May 4, 2019
Efficacy and safety of an expanded dulaglutide dose range: A phase 2, placebo-controlled trial in patients with type 2 diabetes using metforminJuan P Frias, Alan G Wynne, Beata Matyjaszek-Matuszek, et al.
International Journal of Cardiology|April 3, 2012
Implications of pre-procedural TIMI flow in patients with non ST-segment elevation acute coronary syndromes undergoing percutaneous coronary revascularization: insights from the ACUITY trialGiuseppe De Luca, Sorin J Brener, Roxana Mehran, et al.
The American Journal of Cardiology|September 29, 2005
Comparison of coronary stenting versus conventional balloon angioplasty on five-year mortality in patients with acute myocardial infarction undergoing primary percutaneous coronary interventionRajendra H Mehta, Kishore J Harjai, David A Cox, et al.
American Heart Journal|July 24, 2007
Impact of collateral flow on myocardial reperfusion and infarct size in patients undergoing primary angioplasty for acute myocardial infarctionPaul Sorajja, Bernard J Gersh, Roxana Mehran, et al.
The American Journal of Cardiology|March 7, 2006
Prediction of one-year mortality among 30-day survivors after primary percutaneous coronary interventionsRajendra H Mehta, William W O'neill, Kishore J Harjai, et al.
Pageof 17

Showing results (31-40 of 164) with videos related to

Sort By:
Pageof 17
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|February 19, 2011
A clinical risk score for the prediction of very late stent thrombosis in drug eluting stent patientsKenneth W Baran, John M Lasala, David A Cox, et al.
The American Journal of Cardiology|December 3, 2014
Effect of anemia on frequency of short- and long-term clinical events in acute coronary syndromes (from the Acute Catheterization and Urgent Intervention Triage Strategy Trial)Vijay Kunadian, Roxana Mehran, A Michael Lincoff, et al.
Circulation. Cardiovascular Interventions|February 2, 2010
Impact of femoral vascular closure devices and antithrombotic therapy on access site bleeding in acute coronary syndromes: The Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) trialTimothy A Sanborn, Ramin Ebrahimi, Steven V Manoukian, et al.
Diabetes, Obesity & Metabolism|June 23, 2021
Efficacy and safety of dulaglutide 3.0 and 4.5 mg in patients aged younger than 65 and 65 years or older: Post hoc analysis of the AWARD-11 trialJuan P Frias, Enzo Bonora, Luis Nevárez Ruiz, et al.
Diabetes Care|January 5, 2021
Efficacy and Safety of Dulaglutide 3.0 mg and 4.5 mg Versus Dulaglutide 1.5 mg in Metformin-Treated Patients With Type 2 Diabetes in a Randomized Controlled Trial (AWARD-11)Juan P Frias, Enzo Bonora, Luis Nevarez Ruiz, et al.
Diabetes, Obesity & Metabolism|May 4, 2019
Efficacy and safety of an expanded dulaglutide dose range: A phase 2, placebo-controlled trial in patients with type 2 diabetes using metforminJuan P Frias, Alan G Wynne, Beata Matyjaszek-Matuszek, et al.
International Journal of Cardiology|April 3, 2012
Implications of pre-procedural TIMI flow in patients with non ST-segment elevation acute coronary syndromes undergoing percutaneous coronary revascularization: insights from the ACUITY trialGiuseppe De Luca, Sorin J Brener, Roxana Mehran, et al.
The American Journal of Cardiology|September 29, 2005
Comparison of coronary stenting versus conventional balloon angioplasty on five-year mortality in patients with acute myocardial infarction undergoing primary percutaneous coronary interventionRajendra H Mehta, Kishore J Harjai, David A Cox, et al.
American Heart Journal|July 24, 2007
Impact of collateral flow on myocardial reperfusion and infarct size in patients undergoing primary angioplasty for acute myocardial infarctionPaul Sorajja, Bernard J Gersh, Roxana Mehran, et al.
The American Journal of Cardiology|March 7, 2006
Prediction of one-year mortality among 30-day survivors after primary percutaneous coronary interventionsRajendra H Mehta, William W O'neill, Kishore J Harjai, et al.
Pageof 17